Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-042789
Filing Date
2010-02-26
Accepted
2010-02-26 15:39:50
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1765763
2 MULDELTA DEVELOPMENT AND LICENSE AGREEMENT dex10272.htm EX-10.272 304220
3 MULDELTA MASTER SERVICES AGREEMENT dex10273.htm EX-10.273 129082
4 TOPO DEVELOPMENT AND LICENSE AGREEMENT dex10274.htm EX-10.274 307639
5 TOPO MASTER SERVICES AGREEMENT dex10275.htm EX-10.275 130915
6 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 47667
7 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1438
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9708
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9784
10 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 2839
11 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 2848
  Complete submission text file 0001193125-10-042789.txt   2713334
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 10638981
SIC: 8731 Services-Commercial Physical & Biological Research